Abstract
Background: Nonsteroidal antiinflammatory drugs (NSAIDs) may exacerbate coronavirus disease 2019 (COVID-19) and worsen associated outcomes by upregulating the enzyme that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to in order to enter cells.
Methods: We conducted a cohort study using South Korea’s nationwide healthcare database, which contains data for all individuals who received a COVID-19 test (n = 69 793) as of 8 April 2020. We identified adults hospitalized with COVID-19, where cohort entry was the date of hospitalization. NSAID users were those prescribed NSAIDs in the 7 days before and including cohort entry, and nonusers were those not prescribed NSAIDs during this period. Our primary outcome was a composite of in-hospital death, intensive care unit admission, mechanical ventilation use, and sepsis; our secondary outcomes were cardiovascular complications and acute renal failure. We conducted logistic regression analysis to estimate odds ratio (OR) with 95% confidence intervals (CIs) using inverse probability of treatment weighting to minimize confounding.
Results: Of 1824 adults hospitalized with COVID-19 (mean age, 49.0 years; female, 59%), 354 were NSAID users and 1470 were nonusers. Compared with nonuse, NSAID use was associated with increased risks of the primary composite outcome (OR, 1.54; 95% CI, 1.13-2.11) but insignificantly associated with cardiovascular complications (OR, 1.54; 95% CI, 0.96-2.48) or acute renal failure (OR, 1.45; 95% CI, 0.49-4.14).
Conclusions: While awaiting the results of confirmatory studies, we suggest NSAIDs be used with caution for COVID-19 patients as the harms associated with their use may outweigh their benefits.
Keywords: adverse outcomes; coronavirus disease 2019; nationwide study; nonsteroidal antiinflammatory drugs; pharmacoepidemiologic study.
【저자키워드】 Coronavirus disease 2019, adverse outcomes, nationwide study, nonsteroidal antiinflammatory drugs, pharmacoepidemiologic study., 【초록키워드】 COVID-19, Treatment, coronavirus disease, SARS-CoV-2, Coronavirus disease 2019, coronavirus, intensive care, mechanical ventilation, Hospitalization, Sepsis, outcome, severe acute respiratory syndrome Coronavirus, database, adverse outcomes, nonsteroidal antiinflammatory drugs, cohort study, NSAIDS, Probability, Cohort, cells, healthcare, female, age, respiratory, South Korea, Admission, COVID-19 patients, intensive care unit admission, NSAID, renal failure, cardiovascular complications, Odds ratio, acute renal failure, Composite, COVID-19 test, COVID-19 patient, In-hospital death, cardiovascular complication, acute respiratory syndrome, Logistic regression analysis, Primary outcome, 95% CI, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, 95% confidence interval, increased risk, enzyme, caution, individual, secondary outcome, while, Weighting, antiinflammatory, bind, conducted, upregulating, exacerbate, adults hospitalized, antiinflammatory drug, CIs, Nonsteroidal, with COVID-19, 【제목키워드】 drug, clinical, Adverse, South, Nonsteroidal,